RobertSWagnerBBoulangerMRicherM. Aprotinin. Ann Pharmacother1996; 30: 372–80.
2.
BidstrupBPHarrisonJRoystonDTaylorKMTreasureT. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg1993; 55: 971–6.
3.
DietrichWBarankayAHahnelCHRichterJA. High-dose aprotinin in cardiac surgery: three years' experience in 1784 patients. J Cardiothorac Vasc Anesth1992; 6: 324–7.
4.
CosgroveDMHericBLytleBWTaylorPCNovoaRGoldingLA. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg1992; 54: 1031–8.
5.
LemmerJHStanfordWBonneySLBreenJFChemkaEVEldridgeWJ. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg1994; 107: 543–53.
6.
LevyJHPifarreRSchaffHVHorrowJCAlbusRSpiessB. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation1995; 92: 2236–44.
7.
RoystonD. Intraoperative coronary thrombosis: can aprotinin be incriminated (editorial)?J Cardiothorac Vasc Anesth1994; 8: 137–41.
